LABD ETF Chart
NYSEARCA: LABDDirexion FundsTrading--Inverse EquityETFUSD
Market open · Delayed 15 min · as of Oct 8, 12:52 PM ET
LABD technical summary
LABD is trading 18.2% above its 50-day simple moving average of $7.27 and 35.6% below its 200-day average of $13.33. The 50-day average is below the 200-day average, a configuration technical analysts associate with a longer-term downtrend. The 14-day Relative Strength Index (RSI) is 60.4, within the neutral 30 to 70 band.
Over the past year, the stock ranged from $5.81 (Aug 25, 2026) to $37.74 (Oct 7, 2025); the current price sits 9% of the way from the low to the high. Annualized 30-day volatility is 73.9%. Based on the last session's high, low and close, the classic pivot point is $8.06, with first resistance at $8.36 and first support at $7.77.
These indicators describe past price behavior for Direxion Daily S&P Biotech Bear 3X; they are not predictions.
Summary generated from market data by MetaCap's automated system. Methodology
LABD performance
1 week
+14.94%
1 month
+20.96%
3 months
+15.10%
6 months
-47.09%
Year to date
-61.63%
1 year
-77.89%
3 years
-96.55%
5 years
-96.23%
LABD price return, excluding dividends.
Moving averages
| Period | Simple (SMA) | Exponential (EMA) |
|---|---|---|
| 5-day | 7.65Price above | 7.71Price above |
| 10-day | 7.43Price above | 7.51Price above |
| 20-day | 7.36Price above | 7.35Price above |
| 50-day | 7.27Price above | 7.65Price above |
| 100-day | 9.10Price below | 9.42Price below |
| 200-day | 13.33Price below | 13.98Price below |
Pivot points
| Level | Price |
|---|---|
| Resistance 3 (R3) | 8.96 |
| Resistance 2 (R2) | 8.65 |
| Resistance 1 (R1) | 8.36 |
| Pivot point | 8.06 |
| Support 1 (S1) | 7.77 |
| Support 2 (S2) | 7.46 |
| Support 3 (S3) | 7.18 |